Oddity Tech Ltd. (NASDAQ: ODD) is a consumer tech platform aiming to disrupt the beauty and wellness market with data-driven, online brands. It owns digital-first cosmetics brands IL MAKIAGE and SpoiledChild, leveraging AI, computer vision, and a proprietary data platform to serve ~50 million users globally (www.globenewswire.com). Oddity went public in July 2023 with a ~$424 million IPO (priced at $35/share), and saw a strong first-day pop of ~35% (closing ~$47.5) amid enthusiasm for its tech-driven model (www.happi.com). However, in mid-2024 a securities class action lawsuit was filed against Oddity (and certain executives) on behalf of investors who bought shares between the IPO (July 19, 2023) and May 20, 2024 (www.finansavisen.no). The suit followed a short-seller’s report alleging that Oddity misled investors about key aspects of its business. This report delves into Oddity’s fundamentals – from dividends and debt to valuation – and unpacks the risks, red flags, and open questions investors must consider in light of the class action.
Dividend Policy & Shareholder Returns
No Dividend History: Oddity has never paid a cash dividend on its stock and explicitly does not anticipate paying dividends for the foreseeable future (companiesmarketcap.com). Management intends to reinvest earnings into business growth rather than distribute cash, stating that investors “seeking cash dividends should not purchase our shares” (companiesmarketcap.com) (companiesmarketcap.com). In other words, Oddity is firmly a growth company, and any return for shareholders will come via stock price appreciation (not recurring income). Metrics like FFO or AFFO – commonly used for dividend-paying REITs – don’t apply here, as Oddity is a consumer/tech firm. Instead, the company emphasizes Adjusted EBITDA and free cash flow to gauge performance (companiesmarketcap.com) (www.globenewswire.com). Notably, Oddity’s free cash flow generation has been strong – $134 million in 2024 – reflecting high cash conversion of its earnings (www.globenewswire.com).
Share Buybacks: While skipping dividends, Oddity has returned capital to shareholders via stock buybacks. In 2024 the board authorized a $150 million repurchase program, viewing the stock as undervalued. By year-end 2024, the company had bought back 2.35 million shares for ~$100 million in Q4 alone, and $147 million total during 2024, using excess cash (www.globenewswire.com). This is a substantial buyback (for context, the IPO raised only ~$57 million for the company (www.finansavisen.no)). The repurchases reduced share count (~3.7 million shares retired in 2024) and signal management’s confidence in Oddity’s future. However, they also raise questions (covered later) about capital allocation, given the company’s growth opportunities. Net impact: with no dividend, Oddity’s effective “yield” to investors has been through these buybacks, which can boost earnings per share and have returned value to remaining shareholders.
Financial Leverage & Debt Maturities
Low Leverage, Net Cash Position: Oddity carries an extremely conservative balance sheet. As of December 31, 2024, the company held $169 million in cash and investments and had zero outstanding debt (www.globenewswire.com). In fact, Oddity’s 2023 IPO proceeds and strong cash flows have left it in a net cash position, meaning it has more cash than debt. The company did have small legacy borrowings: a 2020 bank term loan (~$1.4 million) and a credit line, but these were fully repaid by the end of 2023 (companiesmarketcap.com) (companiesmarketcap.com). With those paid off, no significant debt maturities loom in the near term. Oddity’s only long-term obligations are standard operational commitments (e.g. leases for its 43 small Israel stores, which are an immaterial part of revenue (www.cosmeticsbusiness.com)).
Available Credit: To bolster liquidity, in January 2024 Oddity secured new credit facilities totaling $100 million from two banks (companiesmarketcap.com). These revolving credit lines give flexibility if needed, at interest rates of approximately SOFR +2.7% (for dollar borrowings) (companiesmarketcap.com). Importantly, the facilities include light financial covenants – requiring Oddity’s equity ratio ≥20% and net debt-to-EBITDA ≤3× (companiesmarketcap.com). Given Oddity’s current net cash status, these covenants are easily met, and the credit line remains undrawn as of the latest reports. In effect, Oddity has ample access to liquidity without actually taking on debt.
Interest Coverage: With **no debt and even net interest income (Oddity earned ~$4.3 million more in interest on its cash than it paid in interest in 2023) (companiesmarketcap.com), interest coverage is not a concern. The company’s EBITDA and cash flows could theoretically cover interest expenses many times over, should it tap the credit line in the future. In 2024, interest expense was negligible, and operating cash flow of $138 million dwarfed any financing costs (www.globenewswire.com). Overall, leverage is very low and Oddity’s balance sheet strength is a key positive – it provides resilience and capacity to invest or withstand downturns. Investors shouldn’t worry about debt maturities or refinancing in the near term, as there are none on the horizon.
Valuation and Comparative Metrics
Stock Performance: Oddity’s stock has been volatile since its IPO. After a strong debut (up ~36% on day one) (www.bloomberg.com) and trading above $50 in 2023, the stock later pulled back into the $30s after the short-seller controversy. As of early 2026, ODD trades around the high-$20s per share, roughly 15–20% below its IPO price. Despite the company’s robust growth (2024 revenue +27% and net income +73% (www.globenewswire.com)), the market has de-rated the stock amid controversy and rising expenses.
Earnings Multiple: At ~$29 per share, Oddity’s valuation looks modest relative to its financials. The stock trades at roughly 15× trailing earnings (P/E ≈15) (www.alphaspread.com) (www.alphaspread.com), which is a discount to both the broad market and peer high-growth beauty companies. For instance, e.l.f. Beauty – another fast-growing cosmetics company – carries a P/E over 30 (www.macrotrends.net). In other words, investors are currently paying about half as much for each dollar of Oddity’s earnings compared to what they pay for e.l.f.’s earnings. On a cash flow basis, Oddity’s enterprise value is ~12.6× its EBITDA (valueinvesting.io), again markedly lower than peers. E.l.f.’s EV/EBITDA is ~27.8× (valueinvesting.io) – more than double Oddity’s – reflecting the market’s greater confidence and enthusiasm for e.l.f., or conversely, a skepticism/discount applied to Oddity. Even large established cosmetics players often trade at higher multiples. This relative undervaluation may suggest upside if Oddity can dispel investor concerns, or it may indicate the market’s cautious view of Oddity’s risks.
Yield and Other Metrics: With no dividend, Oddity’s earnings yield (inverse of P/E) is about 6.5%, which is decent for a growth company. Its EV/Sales is around 2.1× (market cap ~$1.7B vs. $776M–$785M 2025e revenue guidance) (www.stocktitan.net) (www.stocktitan.net), reasonable given a ~20% growth rate. By comparison, e.l.f. trades at ~7× sales (reflecting its premium positioning). Oddity’s free cash flow yield is also attractive – free cash flow in 2024 was $134M (www.globenewswire.com), about a ~8% yield on the recent enterprise value. Overall, valuation metrics imply a cautious market outlook. The stock’s low multiples suggest that investors are pricing in the potential risks and slowing growth (e.g. 2025 EBITDA is guided to only +3–5% growth (www.stocktitan.net) (www.stocktitan.net) with margins dipping). Should Oddity overcome its controversies and continue double-digit growth, there may be room for multiple expansion. On the other hand, if the alleged issues erode its growth or credibility, the low valuation may be justified.
Risks, Red Flags, and Lawsuit Allegations
Oddity’s lofty promises have come under scrutiny. The class action lawsuit filed in mid-2024 highlights several red flags that investors must weigh. According to the complaint, Oddity misled investors or failed to disclose critical facts during the IPO period (www.globenewswire.com): (i) It allegedly overstated the sophistication and role of its AI technology in driving sales; (ii) Its impressive repeat-purchase rates and revenue growth were at least partly fueled by unsustainable or deceptive sales practices; and (iii) The company downplayed the scope of ongoing legal proceedings** against it and its subsidiaries (www.globenewswire.com). In plainer terms, the lawsuit asserts that Oddity’s business may not be as “tech-driven” and healthy as it claimed – and that it concealed legal troubles.
The trigger for these allegations was a scathing report published on May 21, 2024 by NINGI Research, a short-seller. Ningi’s investigation claimed that Oddity had “completely misled investors about every critical aspect of its business,” going so far as to call the company’s celebrated AI platform “nothing but a questionnaire” (www.businesswire.com). The report raised serious concerns about Oddity’s core operating metrics: it suggested that the high repeat purchase rates (a key driver of growth) were artificially inflated by customers being unknowingly enrolled in non-cancelable subscription plans (www.businesswire.com). Essentially, Ningi found that many customers were allegedly “lured into bogus AI quizzes” that led them to unwittingly subscribe, so Oddity could book “repeat” orders in subsequent quarters even if those customers never intended to buy again (www.cosmeticsbusiness.com) (www.cosmeticsbusiness.com). This tactic, if true, would mean Oddity’s growth is less genuine and more a result of aggressive marketing traps – a huge red flag. Ningi’s report also uncovered “hundreds of undisclosed lawsuits” against Oddity and its subsidiaries in the U.S. and Israel – often for unpaid bills or consumer protection violations – including multiple pending class actions in recent years (www.businesswire.com). Many of these lawsuits predated the IPO, raising concerns that Oddity did not fully inform investors of ongoing legal risks. On the day these revelations hit, Oddity’s stock plunged over 7% (www.businesswire.com), and continued to slide in the ensuing days. The market’s reaction showed that these trust factors – AI legitimacy, quality of revenue, and legal compliance – are material to investors’ valuation of Oddity.
Company Response: Oddity forcefully denies the allegations, calling the short-seller’s claims “demonstrably false” and “malicious” (www.globenewswire.com). The company immediately issued a detailed rebuttal on May 21, 2024, addressing each point. First, Oddity insisted its AI and tech are real drivers of customer conversion and loyalty – not a sham (www.globenewswire.com). Management “firmly stands behind” its technology, crediting it for the company’s large scale and high profitability as a fully online business (www.globenewswire.com). Second, Oddity defended its customer practices, saying the horror stories represent only a tiny fraction of orders and that the “non-cancelable plan” claim is false (www.cosmeticsbusiness.com). They point to tens of thousands of 4- and 5-star customer reviews and emphasize that they address any dissatisfaction promptly (www.globenewswire.com). Third, regarding the legal actions, Oddity acknowledged the lawsuits but downplayed their significance – stating that the “hundreds of lawsuits” were mostly small claims related to its Israel brick-and-mortar stores and amounted to less than $100,000 in aggregate (www.globenewswire.com). The company noted these local store issues are immaterial (its 43 retail shops in Israel contribute <5% of revenue and EBITDA) (www.cosmeticsbusiness.com). In short, Oddity portrays the short-seller’s report as inaccurate and not reflective of the business’s true health. It’s worth noting that Oddity has continued to post strong financial results since the report – beating guidance in each subsequent quarter of 2024 (www.globenewswire.com) (www.stocktitan.net) – which lends some credibility to management’s claims that the core business remains solid. However, the reputational damage and uncertainty from these allegations remain a cloud over the stock. Investors will have to watch the legal process play out (the class-action is ongoing, with a lead plaintiff yet to be named as of late 2024) and see if any evidence substantiates the claims of misconduct.
Insider Selling & Control: Another red flag is Oddity’s corporate governance. The IPO itself was heavily weighted toward insider liquidity – of the ~$395 million raised at IPO, about $338 million (85%) went to selling shareholders (including the CEO), while only ~$57 million went to the company’s coffers for growth initiatives (www.finansavisen.no). Such a large insider cash-out at IPO can signal a lack of longer-term confidence or alignment. Additionally, Oddity employs a dual-class share structure that concentrates control with its co-founder/CEO. Oddity’s Class B shares (all held by CEO Oran Holtzman) carry 10 votes each, versus one vote for Class A shares (companiesmarketcap.com) (companiesmarketcap.com). As a result, Holtzman controls roughly 76% of the voting power (companiesmarketcap.com) despite owning a minority of total equity. This majority voting control means public shareholders have little say in governance; the founder can single-handedly elect the board and decide any matter requiring shareholder approval. Such structures pose a risk if management’s interests diverge from those of outside investors – for example, prioritizing aggressive growth or personal payouts over minority shareholder concerns. So far, Holtzman and his team have executed well operationally, but the class action allegations raise questions about transparency and oversight that are harder for outside owners to press when insider control is so strong.
Other Risks: Oddity faces typical risks for a consumer-tech growth company. It relies heavily on online marketing and social media influencers to drive sales; any backlash (e.g. negative viral content or higher customer acquisition costs) could hurt growth (companiesmarketcap.com) (companiesmarketcap.com). Competition in beauty is fierce – established giants (Estée Lauder, L’Oréal) and upstart brands alike are investing in AI and digital strategies. If Oddity’s much-touted technology doesn’t continue to give it an edge in customer conversion, its growth could slow. The company is also expanding into new product categories (“Brand 3” and “Brand 4” are in development (www.globenewswire.com)), which carries execution risk. Lastly, regulatory scrutiny could increase: if there is truth to claims of deceptive subscription practices, Oddity may face investigations or need to modify its sales approach to comply with consumer protection laws. The California Automatic Renewal Law, for example, requires easy cancellation of subscription plans – something Oddity will need to be vigilant about if its current model walks too close to the line.
In summary, Oddity’s risks center on trust and execution. The class action encapsulates those issues: Is Oddity’s growth as high-quality as it claims, and is management being forthright with investors and customers? These uncertainties have clearly weighed on the stock’s valuation.
Open Questions for Investors
1. How Will the Class Action Resolve? The securities lawsuit is in early stages, and its outcome could take years. Will Oddity fight the claims successfully, or will evidence emerge supporting the allegations? A damaging discovery (for instance, proof that the company knowingly misled investors or customers) could not only lead to a settlement/penalties but also dent the brand’s reputation and customer goodwill. Conversely, if Oddity prevails or the case is dismissed, it would remove a major overhang. Investors are awaiting clarity – in the meantime, legal fees and management distraction bear watching. Any updates on the case, or related regulatory actions, will be key in the coming quarters.
2. Are Repeat Revenues Sustainable and Legitimate? A core question is whether Oddity’s impressive repeat purchase rates are organic – driven by customer satisfaction – or if they relied on the kind of “dark pattern” subscriptions alleged by Ningi Research (www.cosmeticsbusiness.com). Oddity vehemently denies using indefensible tactics (www.cosmeticsbusiness.com). Going forward, watch for any changes in Oddity’s disclosures or policies: for example, more transparent subscription opt-ins or easier cancellation processes. Also monitor the customer retention metrics that management shares. If repeat sales were artificially inflated, we would expect to see a hit to customer retention or lifetime value as those practices are corrected. On the other hand, if Oddity’s practices are sound, its high repeat purchase rates should continue, validating the business model. This will directly impact growth – sustainable repeat business means higher lifetime value and lower marketing spend per customer, whereas a drop-off would force Oddity to spend more to acquire new customers.
3. Will ODDITY Need to Alter Its AI/Tech Claims? Oddity markets itself as an AI-driven company – this was central to its IPO narrative. If the “AI is just a questionnaire” criticism holds any truth (www.businesswire.com), Oddity might need to enhance its technology or at least its messaging. Investors should look for how much the company invests in R&D (e.g. its ODDITY Labs initiative developing new beauty molecules) and whether it can demonstrate tangible tech advantages. The open question is can Oddity maintain a tech leadership story in beauty, or will it be seen as simply a well-run D2C cosmetics seller? The answer will influence what valuation multiples it justifies. If it’s truly a tech platform with scalable IP, the market may afford it a tech-like premium; if not, it may be valued closer to traditional cosmetics retailers.
4. Growth vs. Profitability – Can Both Be Delivered? Oddity’s 2024 results showed excellent growth and profitability together (www.globenewswire.com). However, guidance for 2025 implies margin pressure (management is targeting ~20% Adjusted EBITDA margin, down from 23%+ in 2024 (www.stocktitan.net) (www.stocktitan.net)) as the company invests in new brands and technology. An open question is whether these investments will pay off in reaccelerating growth. Brand launches in new categories could drive revenue, but if they flop, they’ll dilute margins with little return. Likewise, international expansion is a frontier (the company is still primarily U.S. and Israel focused). Investors will be watching if Oddity can keep growing ~20%+ annually while sustaining healthy margins ~20% – a balance that would support a higher valuation. If growth decelerates further or margins erode beyond plan, the stock could struggle. On the flip side, any upside surprises (e.g. a hit product or faster growth in a new market) would challenge the current pessimistic valuation.
5. Capital Allocation: What Will They Do With Cash? Oddity’s cash generation is strong, and with $169 million cash and no debt (www.globenewswire.com), it has dry powder. Beyond the remaining $103 million authorized for buybacks (www.globenewswire.com), will the company continue to repurchase shares aggressively? Or might it initiate a dividend down the road? Thus far, management seems more inclined to reinvest and buy back stock rather than start a dividend, given the emphasis on growth (companiesmarketcap.com). Another consideration is M&A: Oddity made a small acquisition (Revela, a biotech R&D startup) in 2023, and it could seek to acquire emerging brands or tech to bolster its platform (companiesmarketcap.com). Investors should evaluate management’s capital deployment choices – are they signaling that internal growth opportunities are limited (hence buying back stock), or simply that the stock is too cheap to ignore? How Oddity balances returning cash to shareholders versus fueling expansion will be a telling indicator of management’s confidence in its long-term runway.
6. Governance and Insider Behavior: With the founder’s tight grip on voting power, outside investors are essentially trusting his leadership. Will insider actions inspire confidence or concern? For example, further insider stock sales (beyond the IPO sell-down) would be a negative signal, whereas insiders buying shares on the open market (or not selling despite lock-ups expiring) would be a positive. Additionally, governance practices bear watching – e.g. the independence of the board, and whether the company adds any oversight in light of the allegations. As a public company under the spotlight of a class action, Oddity may choose to enhance compliance and disclosure to rebuild trust. Investors should keep an eye on any governance changes or shareholder-friendly moves (or lack thereof).
In conclusion, Oddity Tech (ODD) presents a mix of strong fundamentals and significant controversy. The company has a profitable, cash-generative business model disrupting the beauty industry’s online segment, with compelling growth prospects. Yet, the overhang of the class action and the credibility questions it raises cannot be ignored. Oddity’s valuation currently reflects a “show me” stance – the stock is cheap if one believes management’s narrative and the longevity of its growth, but justifiably discounted if one harbors doubts about its practices or sustainability. Going forward, investors must monitor how the legal case progresses, whether Oddity’s operational performance stays on track, and if management takes steps to strengthen transparency and corporate governance. The next few quarters – and the handling of the lawsuit – will be pivotal in determining if Oddity can regain the market’s full confidence or if further disappointments lie ahead. Investors should stay tuned for developments on all these fronts, as they will heavily influence ODD’s risk/reward profile moving into 2026 and beyond.
For informational purposes only; not investment advice.
